Skip to main content
. 2017 Feb 23;61(3):e02510-16. doi: 10.1128/AAC.02510-16

TABLE 1.

Impact of the N132G substitution on kinetic parameters of avibactam and clavulanate and the inhibition of KPC-2 and CTX-M-15

β-Lactamase Avibactam
Clavulanate
k2/Ki (M−1 s−1) k−2 (s−1) koff (s−1) kcat (s−1) Km (μM) kcat/Km (M−1 s−1)
KPC-2 (2.1 ± 1.0) × 105 (1.6 ± 0.4) × 10−3 (1.0 ± 0.6) × 10−3 5.2 ± 0.7 36 ± 4 (1.4 ± 0.3) × 105
KPC-2 N132G 53 ± 3 (1.1 ± 0.1) × 10−3 (1.8 ± 1.5) × 10−3 (1.5 ± 0.2) × 10−4 0.35 ± 0.05 430 ± 80
CTX-M-15 (2.1 ± 0.1) × 105 (1.6 ± 0.3) × 10−3 (6.7 ± 1.1) × 10−4 (3.0 ± 0.2) × 10−4 0.032 ± 0.005 (9.4 ± 1.6) × 103
CTX-M-15 N132G 70 ± 6 (2.2 ± 1.7) × 10−4 (3.2 ± 1.7) × 10−5 (1.2 ± 0.1) × 10−4 17 ± 2 7.1 ± 1.0